| Name | Title | Contact Details |
|---|
Urotronic Inc. is an early stage medical device company developing drug/device combination products. Our mission is to develop revolutionary technologies that will transform the urology market through better patient outcomes that are uniquely positioned for today`s healthcare environment.
BioCure is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Corinth MedTech, a small startup company located in Cupertino, CA, and founded in 2014, developed a bipolar transurethral and transcervical resection system intended for endoscopically controlled tissue removal for male patients diagnosed with benign prostatic hyperplasia (BPH), and female patients diagnosed with Abnormal Uterine Bleeding (AUB), fibroids and/or polyps requiring Hysteroscopic tissue removal.
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the Company`s proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex has also developed a blood volume monitor for use in hospitals and surgery centers.
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.